Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01099800 · ClinicalTrials.gov registry record
Asthma Disparities in Latino Children:Acculturation,Illness Representations & CAM
A clinical trial, sponsored by Arizona State University.
- Completed
- Registry status
- 534
- Enrollment target
NCT01099800: Completed study, sponsored by Arizona State University.
NCT01099800 is a clinical trial that has completed, run by Arizona State University. The registered enrollment target is 534 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01099800 has completed, sponsored by Arizona State University.
- COMPLETED
- Registry status
- 534 participants
- Enrollment target
Study Summary
This interdisciplinary multi-level study moves the research in asthma health disparities from descriptive studies of individual constructs and contexts to testing an integrated, multi-factorial model among Latino families and children with asthma. The investigators seek to gain a more thorough understanding of the interaction of individual characteristics, cultural and experiential factors, social-environmental context, and healthcare system factors on parents' illness representations, use of CAM and controller medications, and children's asthma health outcomes. This will be a one-year longitudinal, multi-site (Phoenix, AZ and Bronx, NY) study among samples of Mexican (N=300) and Puerto Rican (N=300) parents and children aged 5-12 who have asthma. Aim #1: Are there differences in illness representations between Mexican and Puerto Rican parents due to social and contextual factors (i.e., acculturation, education, parental age, poverty, child's illness duration, household members with asthma, and parent-healthcare provider relationship)? Aim #2: Are disparities in asthma control between Mexican and Puerto Rican children due to differences in parents' treatment decisions (CAM and controller medication use) and changes in illness representations over a one year period after controlling for the effects of acculturation, social and contextual factors, environmental triggers, and advice received from others?
Primary Outcome
Level of asthma control will be assessed per NAEPP guidelines which incorporate a structured assessment of symptoms and spirometry.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 534 participants |
| Start Date | 2010-06-23 |
| Est. Completion | 2014-08-25 |
What the finished NCT01099800 record still lists
NCT01099800 is an observational study that tracks outcomes without assigning an intervention. The registered 534 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01099800 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01099800 about?
NCT01099800 is a clinical study titled "Asthma Disparities in Latino Children:Acculturation,Illness Representations & CAM". This interdisciplinary multi-level study moves the research in asthma health disparities from descriptive studies of individual constructs and contexts to testing an integrated, multi-factorial model among Latino families and children with asthma. The investigators seek to gain a more thorough under...
What is the current status of trial NCT01099800?
This trial is currently completed. The enrollment target is 534 participants. The study started on 2010-06-23. Estimated completion is 2014-08-25.
Who is sponsoring clinical trial NCT01099800?
This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04910685 · 534 participants · Phase 2
(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis
- NCT06128551 · 534 participants · Phase 1
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- NCT05614739 · 535 participants · Phase 1
FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3
- NCT07091617 · 535 participants · NA
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI